Multi-client Study: Opportunities Assessment for Hepatitis C Therapeutics Market in India

Multi-client Study: Opportunities Assessment for Hepatitis C Therapeutics Market in India

 

RELEASE DATE
31-Dec-2009
REGION
Asia Pacific
Research Code: P38E-01-00-00-00
SKU: HC02310-AP-MR_08258
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC02310-AP-MR_08258
$4,950.00
DownloadLink
ENQUIRE NOW

Description

This research service aims to provide an update on the epidemiology of Hepatitis C, including the prevalence and incidence, Market Engineering measurements, and government initiatives. It also covers patient source, load, and forecasts, while also outlining the key treaters involved. Current diagnostic methods are presented, followed by treatment regimens, their cost, and upcoming product launches. Clinical trials highlighting research into new treatments are also provided, along with an analysis of the pipeline. Additionally, there is a competitive analysis which includes the market structure, major participants, and future trends. This service covers the Hepatitis C therapeutics market in India.

Table of Contents

Market Overview

  • Introduction
  • Context for the Study
  • Research Scope and Segmentation
  • Methodology
  • Restraints

Market Overview

  • Prevalence of Hepatitis C
  • Incidence of Hepatitis C
  • Market Engineering Measurements
  • Government Initiatives

Hepatitis C: Patient Load Source and Forecasts

  • Patient Source and Quantification
  • Key Treaters and Patient Flow
  • Patient Forecasts

Diagnosis and Treatment

  • Diagnostic Tests and Monitoring
  • Treatment Regimens
  • Cost of Treatment

Product Launches

  • Product Launches - Details

Clinical Trials

  • Clinical Trials - Details

Pipeline Analysis

  • Pipeline Analysis Details

Competitive Analysis

  • Competitive Structure

Future Trends

  • Future Trends

Problems Faced by Physicians

  • Asymptomatic Nature of Hepatitis C
  • Low Awareness of Hepatitis C
  • Side Effects of Current Treatment
  • No Treatment Option for Relapsers and Non-responders
This research service aims to provide an update on the epidemiology of Hepatitis C, including the prevalence and incidence, Market Engineering measurements, and government initiatives. It also covers patient source, load, and forecasts, while also outlining the key treaters involved. Current diagnostic methods are presented, followed by treatment regimens, their cost, and upcoming product launches. Clinical trials highlighting research into new treatments are also provided, along with an analysis of the pipeline. Additionally, there is a competitive analysis which includes the market structure, major participants, and future trends. This service covers the Hepatitis C therapeutics market in India.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number P38E-01-00-00-00
Is Prebook No